Viktrup L[au] - Search Results

Year	Number of Results
1992	2
1993	3
1995	1
1998	1
1999	1
2000	1
2001	4
2002	2
2003	1
2004	6
2005	5
2006	2
2007	5
2008	5
2009	3
2010	5
2011	5
2012	9
2013	12
2014	9
2015	7
2017	1
2018	2
2019	3
2020	9
2021	10
2022	16
2023	8

1

The not so hidden impact of interictal burden in migraine: A narrative review.

Vincent M, Viktrup L, Nicholson RA, Ossipov MH, Vargas BB. Vincent M, et al. Among authors: viktrup l. Front Neurol. 2022 Nov 3;13:1032103. doi: 10.3389/fneur.2022.1032103. eCollection 2022. Front Neurol. 2022. PMID: 36408525 Free PMC article. Review.

2

Nerve Growth Factor Signaling and Its Contribution to Pain.

Barker PA, Mantyh P, Arendt-Nielsen L, Viktrup L, Tive L. Barker PA, et al. Among authors: viktrup l. J Pain Res. 2020 May 26;13:1223-1241. doi: 10.2147/JPR.S247472. eCollection 2020. J Pain Res. 2020. PMID: 32547184 Free PMC article. Review.

3

Appendicitis during pregnancy.

Viktrup L, Hee P. Viktrup L, et al. Am J Obstet Gynecol. 2001 Jul;185(1):259-60. doi: 10.1067/mob.2001.112864. Am J Obstet Gynecol. 2001. PMID: 11483951 No abstract available.

4

Treating osteoarthritis pain: mechanisms of action of acetaminophen, nonsteroidal anti-inflammatory drugs, opioids, and nerve growth factor antibodies.

D'Arcy Y, Mantyh P, Yaksh T, Donevan S, Hall J, Sadrarhami M, Viktrup L. D'Arcy Y, et al. Among authors: viktrup l. Postgrad Med. 2021 Nov;133(8):879-894. doi: 10.1080/00325481.2021.1949199. Epub 2021 Jul 12. Postgrad Med. 2021. PMID: 34252357 Review.

5

Nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low-back pain: mechanism of action in the context of efficacy and safety.

Schmelz M, Mantyh P, Malfait AM, Farrar J, Yaksh T, Tive L, Viktrup L. Schmelz M, et al. Among authors: viktrup l. Pain. 2019 Oct;160(10):2210-2220. doi: 10.1097/j.pain.0000000000001625. Pain. 2019. PMID: 31145219 Free PMC article. Review.

6

Stress urinary incontinence in active elderly women.

Viktrup L, Koke S, Burgio KL, Ouslander JG. Viktrup L, et al. South Med J. 2005 Jan;98(1):79-89. doi: 10.1097/01.SMJ.0000146587.06656.98. South Med J. 2005. PMID: 15678640 Review.

7

Safety and adverse event profile of duloxetine.

Wernicke JF, Gahimer J, Yalcin I, Wulster-Radcliffe M, Viktrup L. Wernicke JF, et al. Among authors: viktrup l. Expert Opin Drug Saf. 2005 Nov;4(6):987-93. doi: 10.1517/14740338.4.6.987. Expert Opin Drug Saf. 2005. PMID: 16255658 Review.

8

Pharmacological agents used for the treatment of stress urinary incontinence in women.

Viktrup L, Bump RC. Viktrup L, et al. Curr Med Res Opin. 2003;19(6):485-90. doi: 10.1185/030079903125002126. Curr Med Res Opin. 2003. PMID: 14594520 Review.

9

The impact of stress urinary incontinence on sexual activity in women.

Barber MD, Dowsett SA, Mullen KJ, Viktrup L. Barber MD, et al. Among authors: viktrup l. Cleve Clin J Med. 2005 Mar;72(3):225-32. doi: 10.3949/ccjm.72.3.225. Cleve Clin J Med. 2005. PMID: 15825801 Free article. Review.

10

Coexisting lower urinary tract symptoms and erectile dysfunction: a systematic review of epidemiological data.

Seftel AD, de la Rosette J, Birt J, Porter V, Zarotsky V, Viktrup L. Seftel AD, et al. Among authors: viktrup l. Int J Clin Pract. 2013 Jan;67(1):32-45. doi: 10.1111/ijcp.12044. Epub 2012 Oct 22. Int J Clin Pract. 2013. PMID: 23082930 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

119 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Results by year